Last edition
News about "Kashiv BioSciences and CRISTÁLIA Partner "
Kashiv BioSciences and CRISTALIA Partner to Bring Omalizumab Biosimilar to Latin America
Kashiv BioSciences, LLC (Kashiv), a US-based vertically integrated biopharmaceutical company, has entered into a licensing and supply agreement with CRISTÁLIA, one of Brazil’s leading pharmaceutical companies, to commercialize ADL-018 / bOmalizumab, a proposed biosimilar to Xolair, in Latin America (LATAM).
Kashiv BioSciences And CRISTÁLIA Partner | 14/09/2025 | By Darshana | 186
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy